Pfizer’s and BioNTech’s vaccine is the start of the end of the pandemic

The Economist

9 November 2020 - Its 90% effectiveness is as good as it gets, and bodes well for other vaccines. But getting them quickly to the right people will be hard.

During this coronavirus-blighted year, through many difficult days of isolation and fear, the world has hoped for better times. It has hoped for better treatments for COVID-19, faster testing and better understanding of how SARS-CoV-2 wreaks havoc on the human body. Many of those things have arrived. 

But one hope in particular has been uppermost: that a vaccine may be found. Its fulfilment seems to be in sight.

Read The Economist article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

US , Vaccine , Public health , COVID-19